Device with an insertable plug for occluding the left atrial appendage - Patent application

The innovative design of a plug within the occlusion device's proximal hub, which covers internal threads post-deployment, addresses thrombogenicity issues, enhancing safety and efficacy by minimizing thrombus formation and stroke risk in LAA occlusion devices.

JP2024540740AInactive Publication Date: 2024-11-01BOSTON SCIENTIFIC SCIMED INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2024527088
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-09
Filing Date
2022-11-08
Publication Date
2024-11-01
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing implantable occlusion devices for the left atrial appendage (LAA) face issues with thrombogenicity, leading to device-related thrombus formation and increased risk of ischemic stroke due to exposed metal and threads, which cannot be resolved by current methods.

Method used

The design includes a proximal hub with a recess and a plug that releasably couples with a delivery shaft, featuring internal or external threads and a membrane to block blood clots, with the plug remaining within the recess post-deployment, reducing thrombus formation by covering internal threads.

Benefits of technology

The solution effectively minimizes thrombus formation by ensuring the plug covers the internal threads, thereby reducing the risk of blood clots and device-related complications, enhancing the safety and efficacy of LAA occlusion devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024540740000001_ABST
    Figure 2024540740000001_ABST
Patent Text Reader

Abstract

An occlusion device for implantation within the left atrial appendage includes a proximal hub defining a recess configured to releasably couple with a delivery shaft, a frame coupled to the proximal hub, a membrane coupled to and covering at least a proximal portion of the frame, the membrane comprising a material configured to block passage of blood clots through the membrane, and a plug configured to be received within the recess and to remain in the recess after implantation.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to occlusion devices, and more particularly to implantable occlusion devices for occluding a patient's left atrial appendage, and methods for using such occlusion devices. [Background technology]

[0002] Implantable occlusion devices are available for insertion into the left atrial appendage (LAA) of the heart. Such devices are used, for example, to prevent blood clots from exiting the heart and entering the systemic circulation.

[0003] Generally, these devices are delivered to the LAA through a catheter system that enters the venous circulation and accesses the left atrium through the interatrial septum between the right and left sides of the heart. The catheter is guided through the septum toward the ostium of the left atrial appendage. After capture and insertion into the LAA, the implantable occlusion device is deployed and secured so that it remains within the appendage. Once positioned, the implantable occlusion device is released by the catheter and the catheter system is removed. Over time, the exposed surface structures of the implantable occlusion device that span the ostium of the LAA become covered with tissue. This process is called endothelialization. Each of the known occlusion devices and methods has certain advantages and disadvantages. There remains a need to provide alternative occlusion devices, as well as methods for using occlusion devices. Summary of the Invention

[0004] The present disclosure provides design, material, manufacturing method, and use alternatives for occlusion devices. An exemplary occlusion device for implantation within a left atrial appendage includes a proximal hub defining a recess configured to releasably couple with a delivery shaft, a frame coupled to the proximal hub and extending radially from the proximal hub and then distally, the frame having a proximal portion, an intermediate portion, and a distal portion with a plurality of struts extending between the proximal and distal portions, a membrane coupled to and covering at least the proximal portion of the frame, the membrane comprising a material configured to block passage of blood clots through the membrane, and a plug configured to be received within the recess and to remain within the recess after implantation.

[0005] Alternatively or additionally to the above embodiment, the recess includes an internal thread. Alternatively or additionally to any of the above embodiments, the plug includes male threads that mate with female threads on the recess.

[0006] Alternatively or additionally to any of the above embodiments, the recess has a first axial length and the plug has a second axial length, the first axial length being longer than the second axial length.

[0007] Alternatively or additionally to any of the above embodiments, the plug has a coupling element configured to releasably couple with a distal end of the delivery shaft. Alternatively or in addition to any of the above embodiments, the plug is configured to move between a first position at the distal end of the recess during delivery and a second position at the proximal end of the recess after the delivery shaft is decoupled.

[0008] Alternatively or additionally to any of the above embodiments, when the plug is moved to the second position, the delivery shaft is automatically uncoupled. Alternatively or additionally to any of the above embodiments, the coupling element is a cavity in the proximal face of the plug.

[0009] Alternatively or additionally to any of the above embodiments, the coupling element is an off-center hole in the proximal face of the plug. Alternatively or additionally to any of the above embodiments, the device further comprises a suture extending through the plug and through the distal end of the recess, the suture being configured to extend through the delivery shaft.

[0010] Alternatively or additionally to any of the above embodiments, the plug comprises an expandable material, and a distal region of the plug is secured within a distal region of the recess. Alternatively or additionally to any of the above embodiments, the plug includes a distal plate configured to engage a distal end of the proximal hub.

[0011] Alternatively or in addition to any of the above embodiments, the plug includes a plate and a spring, a first end of the spring is secured to the plate and a second end of the spring is secured to a distal end of the recess, and the spring is biased to extend the plate to a proximal end of the recess.

[0012] Another exemplary occlusion device for implantation within the left atrial appendage includes a proximal hub defining a recess; a frame coupled to and extending distally from the proximal hub, the frame configured to move between a radially collapsed delivery configuration and a radially expanded configuration for engaging an inner wall of the left atrial appendage; a membrane coupled to and covering at least a proximal portion of the frame, the membrane comprising a material configured to block passage of blood clots through the membrane; and a plug disposed within the recess of the proximal hub and configured to releasably couple with a distal end of a delivery shaft, the plug configured to move between a first position at the distal end of the recess during delivery and a second position at the proximal end of the recess after the delivery shaft is uncoupled and configured to remain in the recess following removal of the delivery shaft.

[0013] An exemplary system for implanting an occlusion device in the left atrial appendage includes a flexible delivery catheter, a delivery shaft extending through the delivery catheter, a proximal hub defining a recess configured to releasably couple with the delivery catheter, and a frame coupled to the proximal hub and extending radially from the proximal hub and then distally, the frame having a proximal portion, an intermediate portion, and a distal portion with a plurality of struts extending between the proximal and distal portions, a membrane coupled to and covering at least the proximal portion of the frame, the membrane configured to prevent passage of a blood clot through the membrane, an occlusion device comprising: a plug configured to be received within the recess and to remain in the recess after implantation, the plug having a first connecting element on its proximal end, the delivery shaft having a second connecting element on its distal end, the second connecting element configured to releasably engage the first connecting element on the plug.

[0014] Alternatively or in addition to the above embodiments, the distal end of the delivery shaft includes male threads, the recess includes female threads, and the plug includes male threads, such that when the second connecting element of the delivery shaft engages the first connecting element of the plug, the male threads on the plug and delivery catheter define a continuous thread that mates with the female threads of the recess.

[0015] Alternatively or in addition to any of the above embodiments, the plug is configured to move between a first position at the distal end of the recess during delivery and a second position at the proximal end of the recess after the delivery shaft is decoupled, and the delivery shaft is automatically decoupled.

[0016] Alternatively or in addition to any of the above embodiments, one of the first and second connecting elements is a cavity and the other of the first and second connecting elements is a protrusion configured to engage the cavity.

[0017] Alternatively or in addition to any of the above embodiments, the first connecting element is an off-center hole in the proximal face of the plug and the second connecting element is an off-center protrusion extending distally from the distal end of the delivery shaft, the off-center hole being configured to receive the off-center protrusion.

[0018] Alternatively or in addition to any of the above embodiments, the system further includes a suture having two free ends, the suture extending through the plug, through the distal end of the recess, and through the delivery catheter, the two free ends being positioned proximal to the proximal end of the delivery catheter.

[0019] The above summary of some embodiments, aspects, and / or examples is not intended to describe each embodiment or every implementation of the present disclosure. The following figures and detailed description more particularly exemplify these embodiments. [Brief description of the drawings]

[0020] The present disclosure may be more fully understood from the consideration of the following detailed description of various embodiments in conjunction with the accompanying drawings, in which: [Figure 1] FIG. 1 is a perspective proximal view of a prior art occlusion device. [Diagram 2] 1 is a perspective proximal view of an exemplary occlusion device according to the present disclosure. [Diagram 3] FIG. 3 is a cross-sectional view taken along line 3-3 in FIG. 2. [Figure 4] 3. An enlarged area 4 of FIG. [Figure 5A] FIG. 1 is a perspective view of an exemplary delivery shaft and plug. [Figure 5B] FIG. 5B is an enlarged view of the distal end of the delivery shaft of FIG. 5A. [Figure 5C] FIG. 5B is an enlarged view of the plug of FIG. 5A. [Figure 6A] 5B is a side cross-sectional view of the delivery shaft and plug of FIG. 5A engaged with a portion of the occlusion device shown in FIG. 4 at various stages of deployment. [Figure 6B] Same as above. [Figure 6C] Same as above. [Figure 7] FIG. 6D is an enlarged perspective view of the proximal hub of the occlusion device of FIG. 6C. [Figure 8] FIG. 13 is a perspective view of another plug. [Figure 9A] FIG. 13 is a side cross-sectional view of another exemplary delivery shaft and plug. [Figure 9B] FIG. 9B is a bottom view of the delivery shaft of FIG. 9A. [Figure 9C] FIG. 9B is an enlarged view of the plug of FIG. 9A. [Figure 10A] FIG. 13 is a side cross-sectional view of another exemplary delivery shaft and plug. [Figure 10B] FIG. 10B is a side cross-sectional view of the plug of FIG. 10A within the occlusion device during delivery. [Figure 11A] FIG. 13 is a side cross-sectional view of another exemplary delivery shaft and plug coupled to an occlusion device during delivery. [Figure 11B] FIG. 11B is a side cross-sectional view of the plug of FIG. 11A after removal of the delivery shaft. [Figure 12] 13A-13C are side cross-sectional views of alternative plugs placed within an occlusion device. [Figure 13A] 13A is a side cross-sectional view of another exemplary delivery shaft and plug coupled to an occlusion device during delivery. FIG. [Figure 13B] FIG. 13B is a side cross-sectional view of the plug of FIG. 13A after removal of the delivery shaft.

[0021] While aspects of the disclosure are susceptible to various modifications and alternative forms, details of which have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the disclosure to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0022] For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification. All numerical values ​​are assumed to be modified by the term "about" in this specification, whether or not expressly indicated. The term "about" in the context of numerical values ​​generally refers to a range of numbers that a person skilled in the art would consider equivalent to the recited value (e.g., having the same function or result). In many cases, the term "about" may include numbers that are rounded to the nearest significant figure. Other uses of the term "about" (e.g., in contexts other than numerical values) may be assumed to have their normal customary definitions as understood from and consistent with the context of this specification, unless otherwise specified.

[0023] The recitation of numerical ranges by endpoints includes all numbers within that range, including the endpoints (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5.) Although several suitable dimensions, ranges, and / or values ​​for various components, features, and / or specifications have been disclosed, one of ordinary skill in the art prompted by this disclosure will understand that the desired dimensions, ranges, and / or values ​​may deviate from those expressly disclosed.

[0024] As used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the content clearly dictates otherwise. As used herein and in the appended claims, the term "or" is used generally in the sense of including "and / or," unless the content clearly dictates otherwise. For ease of understanding, it should be noted that certain features of the present disclosure may be described in the singular even though those features may be multiple or repeated within the disclosed embodiments. Each instance of a feature may include and / or be encompassed by the singular disclosure unless expressly stated otherwise. For purposes of brevity and clarity, not all elements of the present disclosure are necessarily shown in each figure or described in detail below. However, it will be understood that the following description may apply equally to any and / or all of the components present in more than one unless expressly stated otherwise. Moreover, for clarity, not all instances of some elements or features are shown in each figure.

[0025] Relative terms such as "proximal," "distal," "advance," "withdraw," and variations thereof may generally be considered with respect to the positioning, orientation, and / or movement of various elements relative to a user / operator / manipulator of the device, with "proximal" and "withdraw" indicating or referring to being closer to or toward the user, and "distal" and "advance" indicating or referring to being farther from or away from the user. In some cases, the terms "proximal" and "distal" may be assigned arbitrarily to facilitate understanding of the disclosure, and such instances will be readily apparent to one of ordinary skill in the art. Other relative terms such as "upstream," "downstream," "inflow," and "outflow" refer to the direction of fluid flow within a body lumen, a lumen such as a blood vessel, or within a device.

[0026] The term "range" may be understood to mean the maximum measurement of a stated or specified dimension, unless the range or dimension in question is preceded by or specified as "minimum," which may be understood to mean the minimum measurement of the stated or specified dimension. For example, an "outer range" may be understood to mean the maximum outer dimension, a "radial range" may be understood to mean the maximum radial dimension, a "longitudinal range" may be understood to mean the maximum longitudinal dimension, and so on. Each instance of "range" may be different (e.g., axially, longitudinally, laterally, radially, circumferentially, etc.), as will be apparent to one of skill in the art from the context of the particular usage. In general, a "range" may be considered the largest possible dimension measured according to the intended application, while a "minimum range" may be considered the smallest possible dimension measured according to the intended application. In some cases, a "range" may generally be measured orthogonally in a plane and / or cross section, but may also be measured differently, such as, but not limited to, angularly, radially, circumferentially (e.g., along an arc), as will be apparent from the particular context.

[0027] The terms "monolithic" and "unitary" are intended to generally refer to one or more elements that are made up of or consist of a single structure or base unit / element. Monolithic and / or unitary elements are intended to exclude structures and / or features that are made by assembling or otherwise joining together multiple separate elements.

[0028] It should be noted that references herein to "embodiments," "some embodiments," "other embodiments," and the like, indicate that the described embodiment may include a particular feature, structure, or characteristic, but that not all embodiments necessarily include that particular feature, structure, or characteristic. Moreover, such phrases do not necessarily refer to the same embodiment. Moreover, when a particular feature, structure, or characteristic is described in connection with an embodiment, it would be within the knowledge of one of ordinary skill in the art to effect the particular feature, structure, or characteristic in connection with other embodiments, unless expressly stated otherwise, whether or not explicitly described. That is, it is contemplated that the various individual elements described below, even if not explicitly shown in a particular combination, can be combined or arranged with one another to form other additional embodiments, or to complement and / or enhance the described embodiments, as would be understood by one of ordinary skill in the art.

[0029] For clarity, certain identifying numerical nomenclature (e.g., first, second, third, fourth, etc.) may be used throughout the description and / or claims to name and / or distinguish between various described and / or claimed features. It should be understood that the numerical nomenclature is not intended to be limiting, but is merely exemplary. In some embodiments, modifications and departures from previously used numerical nomenclature may be made for brevity and clarity. That is, a feature identified as a "first" element may later be referred to as a "second" element, a "third" element, etc., or may be omitted entirely, and / or a different feature may be referred to as the "first" element. The meaning and / or name in each example will be apparent to one of ordinary skill in the art.

[0030] The following description should be read with reference to the drawings, which are not necessarily to scale and in which similar elements in different drawings are numbered the same. The detailed description and drawings are intended to illustrate the present disclosure, but are not intended to limit the present disclosure. Those skilled in the art will recognize that the various elements described and / or shown can be arranged in various combinations and configurations without departing from the scope of the present disclosure. The detailed description and drawings show exemplary embodiments of the present disclosure. However, for clarity and ease of understanding, not all features and / or elements may be shown in each drawing, but the features and / or elements may be understood to be present regardless, unless otherwise specified.

[0031] There is a continuing need to improve implanted occlusion devices, as well as the methods and devices used to deliver them into the left atrial appendage (LAA). In some cases, the exposed metal and threads on the proximal end of the LAA occlusion device, which is exposed to the left atrium, can become thrombogenic, leading to device-related thrombosis (DRT). If DRT is present, the patient cannot be weaned off Warfarin, defeating the purpose of the device. Furthermore, thrombi formed at the proximal end of the device can break loose and cause an ischemic stroke. Reducing DRT would be a desirable advancement in LAA closure devices.

[0032] FIG. 1 illustrates an exemplary implantable occlusion device 1 as disclosed in U.S. Pat. No. 9,913,652, which is incorporated herein by reference. The occlusion device 1 illustrated in FIG. 1 is shown in an expanded, deployed configuration. The occlusion device 1 may be delivered in a collapsed, compressed configuration through a catheter. The occlusion device 1 may be biased into the expanded or deployed configuration by the superelastic nature of the material used to make the frame 2. In the deployed configuration, the device, and more specifically, an occlusion membrane 3 disposed over a proximal region of the device, spans the ostium of the LAA. The occlusion device 1 may include a retention member associated with the periphery of the occlusion device 1. In some embodiments, the retention structure includes a series of barbs 4. The barbs 4 may be configured to penetrate tissue and retain the occlusion device 1 inside the LAA during implantation. The occlusion device of FIG. 1 is a perspective view from the proximal end. In situ, the occlusion membrane 3 completely covers the surface exposed to the interior of the heart chamber. An internally threaded connector 5 releasably couples the device to a threaded delivery shaft. In some cases, exposed threads and recesses in connector 5 may contribute to the DRT.

[0033] 2-4 show the occlusion device 100 with a plug 150 disposed in a recess in the proximal hub 124 and flush with the proximal face of the device, thereby reducing the risk of thrombus. The structure of the frame 120 with barbs 140 and the occlusion membrane 130 as shown in FIG. 2 may be similar to the occlusion device 1 described in U.S. Pat. No. 9,913,652. The occlusion membrane 130 may cover the proximal end of the frame 120 and extend partially along the side of the frame 120. When the device is in place in the LAA, the occlusion membrane 130 spans the ostium and blocks blood clots or mediates blood flow in and out of the LAA. In some embodiments, the occlusion membrane 130 may be a filter member that blocks the passage of blood clots but is permeable to blood flow therethrough. Alternatively, the occlusion membrane 130 may be a material that is impermeable to blood flow. The occlusion membrane 130 may be fabricated from any suitable biocompatible material. These materials include, but are not limited to, ePTFE (e.g., Gore-Tex®), polyester (e.g., Dacron®), PTFE (e.g., Teflon®), silicone, urethane, metal fibers, and other biocompatible polymers.

[0034] As shown in the cross-sectional view of FIG. 3, the occlusion device 100 may have a frame 120 extending radially and distally from a proximal hub 124. The frame 120 may include a proximal portion, an intermediate portion, and a distal portion. The frame 120 may be formed from a number of struts 122 joined at the proximal hub 124 and the distal hub 126. A number of hooks or barbs 140 may extend radially outward from some of the struts 122. The barbs 140 may serve to anchor the device within the LAA. As shown in the enlarged view of FIG. 4, the number of struts 122 may be joined at the proximal hub 124. The proximal hub 124 may include an inner member 125 defining a recess 127 having internal threads 128. The internal threads 128 may extend along the entire axial length of the recess 127. A plug 150 is disposed within the recess 127.

[0035] FIG. 5A illustrates a delivery shaft 160 configured to engage the occlusion device 100 during delivery through a catheter (not shown). The delivery shaft 160 may have a flared skirt 162 and a threaded distal end 164. The plug 150 may be releasably coupled to the threaded distal end 164. FIG. 5B is a close-up view of the threaded distal end 164 of the delivery shaft 160 uncoupled from the plug 150. The plug 150 may have a first coupling element configured to releasably couple with a second coupling element on the distal end of the delivery shaft 160. In the example shown in FIG. 5B, the threaded distal end 164 may include a distally extending protrusion 166. FIG. 5C shows the plug 150 of FIG. 5A uncoupled from the delivery shaft 160. The proximal face 156 of the plug 150 may have a cavity 154 configured to receive a protrusion 166 of the threaded distal end 164 of the delivery shaft 160. The plug 150 may have male threads 152 configured to mate with the female threads 128 in the recess of the proximal hub 124. The engagement between the protrusion 166 and the cavity 154 may be similar to a screwdriver and screw, tight enough to prevent the protrusion 166 from twisting out of the cavity 154, but loose enough to allow the protrusion 166 to be removed from the cavity 154 when the two parts are not threaded into the recess 127. In the embodiment shown in FIGS. 5A-5C, the threaded distal end 164 and the plug 150 have male threads that form a continuous thread when the plug 150 is coupled to the threaded distal end 164 of the delivery shaft 160. The continuous threads allow the plug 150 and threaded distal end 164 to be threaded in and out of the recess 127 as a single unit.

[0036] In FIG. 6A, the delivery shaft 160 and associated plug 150 of FIG. 5A are shown threaded into the recess 127 of the proximal hub 124 of the occlusion device 100 of FIGS. 2-4. A flared skirt 162 may be configured to engage the proximal hub 124. A threaded distal end 164 may be provided on an inner wire 168 that extends proximally through the delivery shaft 160. In some embodiments, the inner wire 168 may be slidable relative to the delivery shaft 160. In other embodiments, the threaded distal end 164 may be provided on the distal end of the delivery shaft 160. As shown, the threaded distal end 164 and the male threads 152 on the plug 150 are threadably engaged with the female threads 128 of the recess 127 of the proximal hub 124.

[0037] The recess 127 may have a first axial length and the plug 150 may have a second axial length, the first axial length being longer than the second axial length. This allows the plug 150 to move along the length of the recess 127 from a first position at the distal end 121 of the recess 127 during delivery, as shown in FIG. 6A, to a second position at the proximal end 123 of the recess 127 after the delivery shaft 160 is decoupled, as shown in FIG. 6C. In some embodiments, the first axial length of the recess 127 may be at least 1.5 times the second axial length of the plug 150. In other embodiments, the first axial length may be twice the second axial length.

[0038] A protrusion 166 on the threaded distal end 164 of the delivery shaft 160 is disposed within the cavity 154 of the plug 150. This engagement rotates the plug 150 with the delivery shaft 160, moving the plug 150 proximally through the recess 127 as the delivery shaft 160 is rotated to withdraw the threaded distal end 164 proximally from the proximal hub 124. As shown in FIG. 6B, the delivery shaft 160 and threaded distal end 164 have been withdrawn proximally until the plug 150 is adjacent the proximal end 123 of the recess 127. Because the plug 150 is coupled to the threaded distal end 164 of the delivery shaft 160 only by the protrusion 166 of the threaded distal end 164 seated in the cavity 154 of the plug 150, once the threads on the threaded distal end 164 no longer engage the internal threads 128 in the recess 127, the protrusion 166 automatically slides out of the cavity 154 and the delivery shaft 160 is uncoupled from the plug 150. The plug 150 remains in the recess 127 and is flush with the proximal end 123 of the recess 127, as shown in FIG. 6C. The plug 150 covers the internal threads 128 and fills the recess 127, thereby reducing thrombus formation. FIG. 7 shows the plug 150 seated in the recess 127, with the proximal face 156 of the plug 150 flush with the proximal end of the proximal hub 124.

[0039] In another embodiment, the engagement structure between the plug 150 and the threaded distal end 164 of the delivery shaft 160 may be reversed. As shown in FIG. 8, the plug 250 may be externally threaded, like the plug 150 described above, but may have a protrusion 254 that may be configured to engage a cavity in the distal end of the delivery shaft 160.

[0040] In another embodiment, instead of a cavity and protrusion coupling the plug 150 and delivery shaft 160 as described above, the coupling element on the plug 350 may be an off-center, axially extending hole 355 in the proximal face of the plug configured to receive an off-center protrusion such as an elongated pin 366 extending distally and off-center from the threaded distal end 364 of the delivery shaft 360, as shown in FIG. 9A. FIG. 9B shows a distal end view of the threaded distal end 364 of the delivery shaft 360 showing the off-center location of the elongated pin 366. FIG. 9C shows a cross-sectional view of the plug 350 showing the off-center location of the axially extending hole 355 configured to receive the elongated pin 366. The hole 355 and the off-center location of the elongated pin 366 provide a torque to rotate the plug 350 with the delivery shaft 360. The remaining structure of the plug 350 and delivery shaft 360 may be the same as the plug 150 and delivery shaft 160 described above. Similar to the plugs 150, 150 described above, the plug 350 covers the female threads 128 and fills the recess 127 in the proximal hub on the occlusion device, thereby reducing thrombus formation.

[0041] Similar to the embodiment shown in FIGS. 6A-6C, in addition to a protrusion 466 on the threaded distal end 464 of the delivery shaft 460 disposed within the cavity 454 of the plug 450, as shown in FIGS. 10A and 10B, the plug 450 may be coupled to the delivery shaft 460 by a suture 470. FIG. 10A shows that the suture 470 is threaded through a lumen in the delivery shaft 460 and the threaded distal end 464, threaded through two separate holes in the plug 450, and back through the delivery shaft 460. The suture has two free ends, and both free ends of the suture 470 may be disposed proximally of the delivery shaft 460. In some embodiments, the suture 470 may be threaded around a lateral pin 429 that extends across the distal end of the recess 427 of the proximal hub 424, as shown in FIG. 10B. When the plug 450 is withdrawn to the proximal end of the recess 427, rotation of the plug 450 can twist the suture 470 between the distal end of the plug 450 and the lateral pin 429, as shown in FIG. 10B. When the delivery shaft 460 is rotated out of the recess 427, releasing the plug 450, the suture maintains the connection between the threaded distal end 464 of the delivery shaft 460 and the plug 450. If the position of the occlusion device needs to be adjusted, the suture 470 can help guide the projection 466 of the threaded distal end 464 of the delivery shaft 460 back into the cavity 454 of the plug 450. The plug 450 can then be threaded back into the distal end of the recess 427, at a point where the threaded distal end 464 of the delivery shaft 460 is also disposed within the recess 427 of the proximal hub 424. The position of the occlusion device can then be adjusted, followed by removal of the delivery shaft 460. Once the delivery shaft 460 is removed from the plug 450, one end of the suture 470 may be pulled to release the suture from the delivery shaft 460 and plug 450. Similar to the plug 150 described above, the plug 450 covers the threads and fills the recess 427 in the proximal hub on the occlusion device, thereby reducing thrombus formation.

[0042] As shown in FIG. 11A, instead of a threaded plug, an expandable plug 550 may be compressed by the threaded distal end 564 of the delivery shaft 560 and positioned within the proximal hub 524. When the occlusion device is in the desired position, the delivery shaft 560 may be unscrewed from the proximal hub 524, allowing the expandable plug 550 to expand and fill the entire recess 527 of the proximal hub 524, as shown in FIG. 11B. The expandable plug 550 thereby reduces thrombus formation. The expandable plug 550 may be self-expandable in the absence of the compressive force of the threaded distal end 564 of the delivery shaft 560. For example, the expandable plug 550 may be made from an expandable material such as a foam, polymer, or silicone. 11B , expandable plug 550 may be secured within a distal region of recess 527 of proximal hub 524 using at least one lateral pin 529 that extends through opposing side walls of proximal hub 524 and through expandable plug 550. In some examples, lateral pin 529 may include two separate pins that extend through proximal hub 524 and into expandable plug 550 from opposite sides. In other embodiments, the distal end of expandable plug 550 may be secured to the distal end of recess 527 using an adhesive or the like.

[0043] In a further embodiment, an expandable plug 650 similar to the expandable plug 550 described above may include a distal plate 657 extending laterally across the recess 627 of the proximal hub 624 to engage the distal end of the proximal hub 624, as shown in FIG. 12. The distal plate 657 may prevent the expandable plug 650 from being removed proximally from the recess 627. The expandable plug 650 and the distal plate 657 may be a single monolithic piece, or the distal plate 657 may be made of a different material and secured to the distal end of the expandable plug 650. As shown in FIG. 12, after removal of the delivery shaft, the expandable plug 650 expands to completely fill the recess of the proximal hub 624 of the occlusion device, thereby reducing thrombus formation.

[0044] Alternatively, in another embodiment, the plug takes the form of a spring loaded plate 757, as shown in Figures 13A and 13B. During delivery, the threaded distal end 764 of the delivery shaft 760 may be threaded into the female threaded recess 727 and abut the plate 757, compressing the spring 750. The spring 750 may have a first end secured to the plate 757 and a second end secured to the distal end of the recess 727 of the proximal hub 724. See Figure 13A. The distal end of the threaded distal end 664 may be flat to engage a flat proximal surface of the plate 757. 13B, as the threaded distal end 764 of the delivery shaft 760 is unthreaded and removed from the proximal hub 724 of the occlusion device, the spring 750 is biased such that the spring 750 expands and extends the plate 757 to the proximal end of the recess 727. As shown in FIG. 13B, with the proximal surface of the plate 757 flush with the proximal end of the proximal hub 724, the plate 757 covers the recess 727 and its internal threads, thereby reducing thrombus formation.

[0045] Although the protrusions 166, 254, 466 and their mating cavities 154, 454 are shown in the figures as longitudinal protrusions and slots / grooves as found in a conventional flat head screwdriver and screw, it will be understood that the geometry of the mating elements can be any that achieves a mating configuration of the protrusions that fit within the cavities and allows the two associated parts to rotate together and then separate as described above. Some exemplary geometries for alternative protrusions and associated cavities include the following geometries of drill and driver bits: square, hexagon, pentagon, cross (Phillips), Torx®, security Torx®, Tri-Wing®, spline, spanner, Pozidriv®, hex socket / Allen®, square recess, clutch, Mortorq®, Frearson, supadriv, Polydrive®, double square, Bristol, Torq-set®, one-way, pentalobe, TP3, TTAP, and triangle / TA.

[0046] The plugs 150, 250, 350, 450, 550, 650, 757 may be made from and / or coated with a polymer that resists thrombus, such as polytetrafluoroethylene (PTFE), or may be metallic, with or without a coating or surface texture that is advantageous for healing and biocompatibility. The coating may be an anti-thrombogenic coating. In some embodiments, the plugs 150, 250, 350, 450, 550, 650, 757 may be made from or coated with a drug eluting composition, e.g., an anti-thrombotic drug composition.

[0047] To deploy the occlusion device 100 within the LAA, the occlusion device 100 is coupled to a delivery shaft 160, such as by a threaded distal end 164 to a plug 150 within a recess 127 in a proximal hub 124 of the occlusion device 100. The occlusion device may be radially collapsed within a flexible delivery catheter and then percutaneously moved through a blood vessel to a desired location. Once the end of the delivery catheter is adjacent to the desired location, the device is deployed, allowing the frame 120 to radially expand to its relaxed size and shape configured to engage the inner wall of the LAA, as shown in FIG. 2. Once the occlusion device 100 is properly positioned and fully deployed, the occlusion device 100 is untethered or released from the delivery shaft 160 by uncoupling the delivery shaft 160 from the plug 150, leaving the plug 150 flush with the proximal end of the proximal hub 124. The plug 150 fills the recess 127 of the proximal hub 124 and covers any internal threads therein, thereby reducing thrombus formation in the proximal hub 124. It will be understood that the above-described method of implanting the occlusion device applies equally to the other exemplary plugs 250, 350, 450, 550, 650, 750.

[0048] The various components of the occlusion device 100, delivery shaft 160, and plug 150 (and / or other systems or components disclosed herein), as well as materials that may be used for the various elements thereof disclosed herein, may include those commonly associated with occlusion devices. For simplicity, the following description refers to the occlusion device 100, delivery shaft 160, and plug 150 (as well as variations, systems, or components disclosed herein). However, this is not intended to limit the devices and methods described herein, and the discussion may apply to other elements, members, components, or devices disclosed herein.

[0049] In some embodiments, the occlusion device 100, delivery shaft 160, and plug 150 (and variations, systems, or components thereof disclosed herein) may be made from metals, metal alloys, ceramics, zirconia, polymers (some examples of which are disclosed below), metal-polymer composites, combinations thereof, and the like, or other suitable materials. Some examples of suitable metals and metal alloys include stainless steels, such as 444V, 444L, and 314LV stainless steels; mild steels; nickel-titanium alloys, such as linear elastic and / or superelastic Nitinol; cobalt chromium alloys, titanium and its alloys, alumina, diamond-like coated (DLC) or titanium nitride coated metals, other nickel alloys, such as nickel-chromium-molybdenum alloys (e.g., UNS:N06625, such as INCONEL® 625, HASTELLOY® C-1000, and other alloys such as chromium-containing alloys, ... 22, UNS:N06022 such as HASTELLOY® C276, other HASTELLOY® alloys, etc.), nickel-copper alloys (e.g., UNS:N04400 such as MONEL® 400, NICKELVAC™ 400, NICORROS® 400, etc.), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS:R44035 such as MP35-N™), nickel-molybdenum alloys (e.g., HASTELLOY® ALL ... B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R44003, such as ELGILOY®, PHYNOX®); platinum strengthened stainless steels; titanium; platinum; palladium; gold; combinations thereof; the like; or any other suitable material.

[0050] As alluded to herein, within the family of commercially available nickel-titanium or nitinol alloys, there is a category termed "linear elastic" or "non-superelastic", which may be chemically similar to conventional shape memory and superelastic species, but may exhibit distinct and useful mechanical properties. Linear elastic and / or non-superelastic nitinol may be distinguished from superelastic nitinol in that linear elastic and / or non-superelastic nitinol does not exhibit a substantial "superelastic plateau" or "flag region" in its stress / strain curve as does superelastic nitinol. Instead, in linear elastic and / or non-superelastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or somewhat but not necessarily completely linear, relationship, or at least a relationship that is more linear than the superelastic plateau and / or flag region that may be seen in superelastic nitinol, until plastic deformation begins. Thus, for purposes of this disclosure, linear elastic and / or non-superelastic nitinol may also be referred to as "substantially" linear elastic and / or non-superelastic nitinol.

[0051] Also, in some cases, linear elastic and / or non-superelastic Nitinol can be distinguished from superelastic Nitinol in that linear elastic and / or non-superelastic Nitinol can tolerate up to about 2-5% strain while remaining substantially elastic (e.g., before plastic deformation), whereas superelastic Nitinol can tolerate up to about 8% strain before plastic deformation. Both of these materials can be distinguished from other linear elastic materials, such as stainless steel (which can also be distinguished based on its composition), which can only tolerate about 0.2-0.44 percent strain before plastic deformation.

[0052] In some embodiments, the linear elastic and / or non-superelastic nickel-titanium alloy is an alloy that does not exhibit a martensite / austenite phase change detectable by differential scanning calorimetry (DSC) and dynamic metal thermal analysis (DMTA) analysis over a wide temperature range. For example, in some embodiments, the linear elastic and / or non-superelastic nickel-titanium alloy may not have a martensite / austenite phase change detectable by DSC and DMTA analysis in the range of about -60°C to about 120°C. Thus, the mechanical bending properties of such materials may be generally inert to the effects of temperature over this wide temperature range. In some embodiments, the mechanical bending properties of the linear elastic and / or non-superelastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, e.g., in that they do not exhibit a superelastic plateau and / or flag region. For example, over a wide temperature range, the linear elastic and / or non-superelastic nickel-titanium alloy maintains its linear elastic and / or non-superelastic properties and / or characteristics.

[0053] In some embodiments, the linear elastic and / or non-superelastic nickel-titanium alloy may range from about 50 to about 60 weight percent nickel, with the remainder essentially titanium. In some embodiments, the composition ranges from about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy, available from Furukawa Techno Materials, Inc., Kanagawa, Japan. Other suitable materials include ULTANIUM™ (available from Neo-Metrics) and GUM METAL® (available from Toyota). In some other embodiments, a superelastic alloy, such as superelastic Nitinol, may be used to achieve the desired properties.

[0054] In at least some embodiments, some or all of the occlusion device 100, delivery shaft 160, and plug 150 (and variations, systems, or components thereof disclosed herein) may also be doped with, made from, or otherwise include radiopaque materials. A radiopaque material is understood to be a material that can produce a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image assists the user in determining the location of the occlusion device 100, delivery shaft 160, and plug 150 (and variations, systems, or components thereof disclosed herein). Some examples of radiopaque materials include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloys, polymeric materials loaded with radiopaque fillers, and the like. Additionally, other radiopaque marker bands and / or coils may also be incorporated into the design of the occlusion device 100, delivery shaft 160, and plug 150 (and variations, systems, or components thereof disclosed herein) to achieve the same results.

[0055] In some embodiments, the occlusion device 100, delivery shaft 160, and plug 150 (as well as variations, systems, or components thereof disclosed herein) and / or portions thereof may be made of or include a polymer or other suitable material. Some examples of suitable polymers include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, e.g., DELRIN® available from DuPont), polyether block esters, polyurethanes (e.g., Polyurethane 85A), polypropylene (PP), polyvinyl chloride (PVC), polyetheresters (e.g., ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (e.g., butylene / poly(alkylene ether) phthalates and / or other polyester elastomers such as HYTREL® available from DuPont), polyamides (e.g., DURETHAN® or Elf® available from Bayer), and / or other suitable materials. Atochem's CRISTAMID™), elastomeric polyamides, block polyamide / ethers, polyether block amides (PEBA, available, for example, under the trade name PEBAX™), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex™ high density polyethylene, Marlex™ low density polyethylene, linear low density polyethylene (e.g., REXELL™), polyesters, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyether ether ketone (PEEK), polyimides (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), polyparaphenylene terephthalamide (e.g., KEVLAR™), polysulfone, nylon, nylon 12 (EMS AmericanSuch materials may include, but are not limited to, GRILAMID® available from Grilon, perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefins, polystyrene, epoxies, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (e.g., SIBS and / or SIBS 50A), polycarbonates, ionomers, polyurethane silicone copolymers (e.g., Elast-Eon™ from AorTech Biomaterials or ChronoSil™ from AdvanSource Biomaterials), biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers, polymer / metal composites, and the like. In some embodiments, the sheath may be blended with a liquid crystal polymer (LCP). For example, the blend may contain up to about 6% LCP.

[0056] In some embodiments, the occlusion device 100 and plug 150 (as well as variations, systems, or components thereof disclosed herein) may include and / or be treated with a suitable therapeutic agent. Some examples of suitable therapeutic agents may include anti-thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine-proline-arginine-chloromethyl-ketone).

[0057] It will be understood that the present disclosure is in many respects merely illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps, without exceeding the scope of the present disclosure. This may include, to the extent appropriate, the use of any of the features of one illustrative embodiment used in other embodiments. The scope of the present disclosure is, of course, defined in the language in which the appended claims are expressed.

Claims

1. 1. An occlusion device for implantation within a left atrial appendage, comprising: a proximal hub defining a recess configured to releasably couple with a delivery shaft; a frame coupled to the proximal hub and extending radially and then distally from the proximal hub, the frame having a proximal portion, an intermediate portion, and a distal portion, the frame including a plurality of struts extending between the proximal portion and the distal portion; a membrane coupled to and covering at least the proximal portion of the frame, the membrane comprising a material configured to block passage of a blood clot therethrough; a plug configured to be received within the recess and to remain within the recess after implantation; 13. An occlusion device comprising:

2. The occlusion device of claim 1 , wherein the recess includes internal threads.

3. The occlusion device of claim 2 , wherein the plug includes external threads that mate with the internal threads on the recess.

4. 4. The occlusion device of claim 3, wherein the recess has a first axial length and the plug has a second axial length, the first axial length being greater than the second axial length.

5. The occlusion device of claim 2 , wherein the plug has a coupling element configured to releasably couple with a distal end of the delivery shaft.

6. 6. The occlusion device of claim 5, wherein the plug is configured to move between a first position at a distal end of the recess during delivery and a second position at a proximal end of the recess after the delivery shaft is decoupled.

7. The occlusion device of claim 6 , wherein the delivery shaft is automatically decoupled when the plug is moved to the second position.

8. The occlusion device of claim 7 , wherein the coupling element is a cavity in a proximal face of the plug.

9. The occlusion device of claim 7 , wherein the coupling element is an off-center hole in a proximal face of the plug.

10. The occlusion device of claim 7 , further comprising a suture extending through the plug and through the distal end of the recess, the suture configured to extend through the delivery shaft.

11. The occlusion device of any one of claims 1 to 10, wherein the plug comprises an expandable material and a distal region of the plug is secured within a distal region of the recess.

12. The occlusion device of claim 11 , wherein the plug includes a distal plate configured to engage a distal end of the proximal hub.

13. 13. The occlusion device of any one of claims 1 to 12, wherein the plug comprises a plate and a spring, a first end of the spring being secured to the plate and a second end of the spring being secured to a distal end of the recess, the spring being biased to extend the plate to a proximal end of the recess.

14. An occlusion device for implantation within a left atrial appendage, a proximal hub defining a recess; a frame coupled to and extending distally from the proximal hub, the frame configured to move between a radially collapsed delivery configuration and a radially expanded configuration for engaging an inner wall of the left atrial appendage; a membrane coupled to and covering at least a proximal portion of the frame, the membrane comprising a material configured to block passage of a blood clot therethrough; a plug disposed within the recess of the proximal hub and configured to releasably couple with a distal end of a delivery shaft, the plug being configured to move between a first position at the distal end of the recess during delivery and a second position at the proximal end of the recess after the delivery shaft is decoupled, and configured to remain within the recess following removal of the delivery shaft; 13. An occlusion device comprising:

15. 1. A system for implanting an occlusion device in a left atrial appendage, comprising: a flexible delivery catheter; a delivery shaft extending through the delivery catheter; 1. An occlusion device comprising: a proximal hub defining a recess configured to releasably couple with the delivery catheter; a frame coupled to the proximal hub and extending radially and then distally from the proximal hub, the frame having a proximal portion, an intermediate portion, and a distal portion, the frame comprising a plurality of struts extending between the proximal portion and the distal portion; a membrane coupled to and covering at least the proximal portion of the frame, the membrane comprising a material configured to block passage of blood clots therethrough; and a plug configured to be received within the recess and remain within the recess after implantation, the plug having a first coupling element at a proximal end of the plug. and an occlusion device comprising: The system, wherein the delivery shaft has a second connecting element on a distal end of the delivery shaft, the second connecting element configured to releasably engage the first connecting element on the plug.

Citation Information

Patent Citations

  • Expandable occlusion device and method of use

    JP2015509752A

  • Wire centering correction device

    JP2017502788A

  • Anti-thrombus feature for implanted medical devices

    US20140114340A1

  • Left atrial appendage implant with continuous covering

    US20210015491A1